Product Code: ETC9942249 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) DNA Repair Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) DNA Repair Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) DNA Repair Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) DNA Repair Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the UK, driving the demand for DNA repair drugs. |
4.2.2 Advancements in biotechnology and pharmaceutical research leading to the development of more effective DNA repair drugs. |
4.2.3 Growing investments in healthcare infrastructure and RD activities in the UK. |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for DNA repair drugs in the UK. |
4.3.2 High cost associated with research, development, and production of DNA repair drugs. |
4.3.3 Limited awareness among healthcare professionals and patients about the benefits of DNA repair drugs. |
5 United Kingdom (UK) DNA Repair Drugs Market Trends |
6 United Kingdom (UK) DNA Repair Drugs Market, By Types |
6.1 United Kingdom (UK) DNA Repair Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By PARP Inhibitors, 2021- 2031F |
6.1.4 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Alkylating Agents, 2021- 2031F |
6.1.5 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) DNA Repair Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Ovarian Cancer, 2021- 2031F |
6.2.4 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.5 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Head and Neck Cancer, 2021- 2031F |
6.2.6 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) DNA Repair Drugs Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Tablets, 2021- 2031F |
6.3.3 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Capsules, 2021- 2031F |
6.3.4 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Injectables, 2021- 2031F |
6.4 United Kingdom (UK) DNA Repair Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.3 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.4 United Kingdom (UK) DNA Repair Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United Kingdom (UK) DNA Repair Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) DNA Repair Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) DNA Repair Drugs Market Imports from Major Countries |
8 United Kingdom (UK) DNA Repair Drugs Market Key Performance Indicators |
8.1 Number of clinical trials conducted for DNA repair drugs in the UK. |
8.2 Rate of adoption of DNA repair drugs in cancer treatment protocols. |
8.3 Success rate of DNA repair drugs in clinical trials and real-world applications. |
8.4 Investment in RD for DNA repair drugs by pharmaceutical companies in the UK. |
8.5 Number of partnerships and collaborations between biotech firms and research institutions for DNA repair drug development in the UK. |
9 United Kingdom (UK) DNA Repair Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) DNA Repair Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 United Kingdom (UK) DNA Repair Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) DNA Repair Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 United Kingdom (UK) DNA Repair Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) DNA Repair Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) DNA Repair Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) DNA Repair Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |